These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

262 related articles for article (PubMed ID: 17662475)

  • 1. Construction and characterization of a stable subgenomic dengue virus type 2 replicon system for antiviral compound and siRNA testing.
    Ng CY; Gu F; Phong WY; Chen YL; Lim SP; Davidson A; Vasudevan SG
    Antiviral Res; 2007 Dec; 76(3):222-31. PubMed ID: 17662475
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterization of an efficient dengue virus replicon for development of assays of discovery of small molecules against dengue virus.
    Yang CC; Tsai MH; Hu HS; Pu SY; Wu RH; Wu SH; Lin HM; Song JS; Chao YS; Yueh A
    Antiviral Res; 2013 May; 98(2):228-41. PubMed ID: 23499649
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dengue virus replicons: production of an interserotypic chimera and cell lines from different species, and establishment of a cell-based fluorescent assay to screen inhibitors, validated by the evaluation of ribavirin's activity.
    Massé N; Davidson A; Ferron F; Alvarez K; Jacobs M; Romette JL; Canard B; Guillemot JC
    Antiviral Res; 2010 Jun; 86(3):296-305. PubMed ID: 20307577
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Construction of self-replicating subgenomic dengue virus 4 (DENV4) replicon.
    Alcaraz-Estrada SL; Del Angel R; Padmanabhan R
    Methods Mol Biol; 2014; 1138():131-50. PubMed ID: 24696335
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of a new dengue virus inhibitor that targets the viral NS4B protein and restricts genomic RNA replication.
    van Cleef KW; Overheul GJ; Thomassen MC; Kaptein SJ; Davidson AD; Jacobs M; Neyts J; van Kuppeveld FJ; van Rij RP
    Antiviral Res; 2013 Aug; 99(2):165-71. PubMed ID: 23735301
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development of a novel Dengue-1 virus replicon system expressing secretory Gaussia luciferase for analysis of viral replication and discovery of antiviral drugs.
    Kato F; Kobayashi T; Tajima S; Takasaki T; Miura T; Igarashi T; Hishiki T
    Jpn J Infect Dis; 2014; 67(3):209-12. PubMed ID: 24858611
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of inhibitors of dengue viral replication using replicon cells expressing secretory luciferase.
    Kato F; Nio Y; Yagasaki K; Suzuki R; Hijikata M; Miura T; Miyazaki I; Tajima S; Lim CK; Saijo M; Takasaki T; Hishiki T
    Antiviral Res; 2019 Dec; 172():104643. PubMed ID: 31678478
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Construction of self-replicating subgenomic West Nile virus replicons for screening antiviral compounds.
    Alcaraz-Estrada SL; Reichert ED; Padmanabhan R
    Methods Mol Biol; 2013; 1030():283-99. PubMed ID: 23821276
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Establishment and Application of Flavivirus Replicons.
    Kümmerer BM
    Adv Exp Med Biol; 2018; 1062():165-173. PubMed ID: 29845532
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vitro efficacy of approved and experimental antivirals against novel genotype 3 hepatitis C virus subgenomic replicons.
    Yu M; Corsa AC; Xu S; Peng B; Gong R; Lee YJ; Chan K; Mo H; Delaney W; Cheng G
    Antiviral Res; 2013 Nov; 100(2):439-45. PubMed ID: 24013001
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development of a novel dicistronic reporter-selectable hepatitis C virus replicon suitable for high-throughput inhibitor screening.
    Hao W; Herlihy KJ; Zhang NJ; Fuhrman SA; Doan C; Patick AK; Duggal R
    Antimicrob Agents Chemother; 2007 Jan; 51(1):95-102. PubMed ID: 17060518
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A high-throughput assay using dengue-1 virus-like particles for drug discovery.
    Qing M; Liu W; Yuan Z; Gu F; Shi PY
    Antiviral Res; 2010 May; 86(2):163-71. PubMed ID: 20153777
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Amodiaquine, an antimalarial drug, inhibits dengue virus type 2 replication and infectivity.
    Boonyasuppayakorn S; Reichert ED; Manzano M; Nagarajan K; Padmanabhan R
    Antiviral Res; 2014 Jun; 106():125-34. PubMed ID: 24680954
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of a small-molecule inhibitor of dengue virus using a replicon system.
    Hsu YC; Chen NC; Chen PC; Wang CC; Cheng WC; Wu HN
    Arch Virol; 2012 Apr; 157(4):681-8. PubMed ID: 22249364
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Construction and applications of yellow fever virus replicons.
    Jones CT; Patkar CG; Kuhn RJ
    Virology; 2005 Jan; 331(2):247-59. PubMed ID: 15629769
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Construction and characterization of subgenomic replicons of New York strain of West Nile virus.
    Shi PY; Tilgner M; Lo MK
    Virology; 2002 May; 296(2):219-33. PubMed ID: 12069521
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Triaryl pyrazoline compound inhibits flavivirus RNA replication.
    Puig-Basagoiti F; Tilgner M; Forshey BM; Philpott SM; Espina NG; Wentworth DE; Goebel SJ; Masters PS; Falgout B; Ren P; Ferguson DM; Shi PY
    Antimicrob Agents Chemother; 2006 Apr; 50(4):1320-9. PubMed ID: 16569847
    [TBL] [Abstract][Full Text] [Related]  

  • 18. West Nile virus infectious replicon particles generated using a packaging-restricted cell line is a safe reporter system.
    Li W; Ma L; Guo LP; Wang XL; Zhang JW; Bu ZG; Hua RH
    Sci Rep; 2017 Jun; 7(1):3286. PubMed ID: 28607390
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High-throughput assays using a luciferase-expressing replicon, virus-like particles, and full-length virus for West Nile virus drug discovery.
    Puig-Basagoiti F; Deas TS; Ren P; Tilgner M; Ferguson DM; Shi PY
    Antimicrob Agents Chemother; 2005 Dec; 49(12):4980-8. PubMed ID: 16304161
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Discovery of small molecule inhibitors of West Nile virus using a high-throughput sub-genomic replicon screen.
    Gu B; Ouzunov S; Wang L; Mason P; Bourne N; Cuconati A; Block TM
    Antiviral Res; 2006 Jun; 70(2):39-50. PubMed ID: 16724398
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.